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Abstract
 
To clarify the link between autoimmune disease and hypercholesterolemia, we created the
 
gld.apoE
 
   
 
 mouse as a model of accelerated atherosclerosis. Atherosclerotic lesion area was
significantly increased in 
 
gld.apoE
 
   
 
 mice compared with 
 
apoE
 
   
 
 mice. 
 
gld.apoE
 
   
 
 mice also
displayed increases in lymphadenopathy, splenomegaly, and autoantibodies compared with 
 
gld
 
mice, and these effects were exacerbated by high cholesterol diet. 
 
gld.apoE
 
   
 
 mice exhibited
higher levels of apoptotic cells, yet a reduced frequency of engulfed apoptotic nuclei within
macrophages. Infusion of lysophosphatidylcholine, a component of oxidized low density lipo-
protein, markedly decreased apoptotic cell clearance in 
 
gld
 
 mice, indicating that hypercholester-
olemia promotes autoimmune disease in this background. These data suggest that defects in
apoptotic cell clearance promote synergy between atherosclerotic and autoimmune diseases.
Key words: atherosclerosis • autoimmunity • macrophages • 
lysophosphatidylcholine • lymphoproliferation
 
Introduction
 
Autoimmune disorders are characterized by the loss of tol-
erance to self-antigen and the consequent production of
immunoglobulin G autoantibodies (1). The development of
autoimmune disease involves a poorly understood interplay
of genetic and environmental factors. Recently, it has been
found that failure to degrade chromatin or properly clear
apoptotic cells contributes to the development of autoim-
munity. Impaired apoptotic debris clearance leads to the
development of an autoimmune phenotype in mouse models
(2, 3). Similarly, in humans, C1q and DNaseI deficiencies are
associated with the development of SLE (4, 5), and apop-
totic bodies and circulating DNA fragments are found in the
sera of patients with SLE (6, 7). Furthermore, macrophages
from patients with SLE display abnormal morphology and
are impaired in their ability to clear apoptotic bodies (8).
Inflammatory cell activity plays an important role in the
progression of atherosclerosis. Atherosclerotic lesions are
initiated by injury to the endothelium by oxidized low
density lipoprotein (oxLDL), inflammatory cytokines, and
immune complexes, and its progression involves inflamma-
tory cell interactions with the endothelium and extravasation
into the subendothelial space (9). Several lines of genetic
evidence in apolipoprotein E–deficient (
 
apoE
 
   
 
) or low
density lipoprotein receptor-deficient mice suggest that
both lymphocytes and macrophages contribute to the
early and late stages of atherosclerotic lesion formation
(10). Patients with autoimmune diseases, including SLE
and rheumatoid arthritis, exhibit a higher incidence of
atherosclerosis and are at significant risk of premature car-
diovascular disease (11–15). There is considerable contro-
versy regarding the causes of atherosclerosis in patients
with autoimmune disease, although chronic inflammation
is likely to be a contributing factor. Progress in under-
standing the mechanisms of accelerated atherosclerosis asso-
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ciated with autoimmune disease has been impaired by the
lack of an appropriate animal model.
Fas is a receptor that initiates an apoptotic signal when
bound to its ligand, FasL (16). Fas-mediated apoptosis
functions in part to control peripheral lymphoid responses
(17) and macrophage survival (18, 19). In humans, dimin-
ished Fas-mediated apoptosis gives rise to Canale-Smith
syndrome, a disease associated with lymphoproliferation
and autoimmunity (20–22). The 
 
gld
 
 and 
 
lpr
 
 mouse strains
have inactivating mutations in FasL and Fas, respectively,
and they suffer from lupuslike autoimmune disorders with
autoantibody specificities similar to those seen with the hu-
man disease (23–26). In addition, they exhibit lymphaden-
opathy and splenomegaly. These mice typically do not ex-
hibit signs of atherosclerosis, but they are susceptible to
atherosclerotic lesion formation when fed an atherogenic
diet containing cholic acid (27).
To develop a better understanding of the link between
atherogenesis and autoimmune disease, we generated an
atherosclerotic mouse model that lacks functional FasL by
crossing 
 
apoE
 
   
 
 with 
 
gld
 
 mice. The 
 
gld.apoE
 
   
 
 mice dis-
played enhanced atherosclerosis compared with 
 
apoE
 
   
 
mice reminiscent of accelerated atherosclerosis seen in
patients with autoimmune disease. These mice also exhib-
ited increased lymphoproliferation and autoimmunity com-
pared with 
 
gld
 
 mice, and this phenotype was enhanced by a
high-fat diet. The 
 
gld.apoE
 
   
 
 mice had high levels of ap-
optotic material both in tissues and in the circulation. This
was due, at least in part, to an impaired ability to scavenge
apoptotic debris, suggesting that synergism between ath-
erosclerosis and autoimmune disease can be mediated by
impaired apoptotic body clearance.
 
Materials and Methods
 
Generation of Mice and Study Protocol.  apoE
 
   
 
 and 
 
gld
 
 mice
were obtained from Jackson ImmunoResearch Laboratories on
the C57BL/6J background. The 
 
gld
 
 mutation is a point mutation
in the FasL gene that occurred spontaneously in the C3H/HeJ
strain (24). Fully congenic C57/B6-
 
gld
 
 mice have been generated
by transferring the 
 
gld
 
 mutation to the C57BL/6J background for
10 generations of backcrossing. Single knockout mice were inter-
bred to produce homozygous groups of mice with the following
genotypes: 
 
apoE
 
   
 
, 
 
gld
 
, 
 
gld
 
.
 
apoE
 
   
 
, and 
 
apoE
 
   
 
gld
 
 
 
/
 
 
 
 (WT).
Mice were maintained on a Purina ProLab 3000 mouse diet
(Normal Diet), and at 7 wk of age, mice from each genotype re-
ceived either normal diet or Teklad adjusted calories Western
diet: 21% (weight/weight) fat, 0.15% (weight/weight) choles-
terol, and 19.5% (weight/weight) casein, without sodium cho-
late. All mouse experiments were performed under protocols ap-
proved by the Institutional Animal Care and Use Committee of
Boston University School of Medicine.
 
PCR Analysis for ApoE Genotype. 
 
The 
 
apoE
 
 genotype was
determined by PCR analysis using DNA extracted from tail sam-
ples (QIAGEN). The 
 
apoE
 
 alleles were detected using three
primers that produced 155-bp or 245-bp products, respectively.
The apoE primers were as follows: 5
 
 
 
-GCCTAGCCGAG-
GGAGAGCCG-3
 
  
 
and
 
 
 
5
 
 
 
-TGTGACTTGGGAGCTCTGC-
AGC-3
 
 
 
 for the wild-type allele and 5
 
 
 
-GCCGCCCCGACTG-
CATCT-3
 
 
 
 for the deficient allele.
 
Gld Mutation Detection by Fluorescent Sequencing. 
 
The 
 
gld
 
-
derived progeny were genotyped by sequence analysis. A 437-bp
PCR fragment was generated with primers GLDF1, 5
 
 
 
-AAC-
CCCCACTCAAGGTCCATCCCTCTG-3
 
 
 
, and GLDR0, 5
 
 
 
-
ATATTCCTGGTGCCCATGAT-3
 
 
 
. The PCR products were
labeled using the PE BigDye Terminator Cycle Sequencing
Ready Reaction Kit (Applied Biosystems), and sequenced. The
area of interest was 
 
 
 
100 bp downstream from the start of the
amplified fragment. In this region, the sequence 5
 
 
 
-CCTTTTT-
3
 
 
 
 indicated the wild-type 
 
FasL
 
 allele, whereas 5
 
 
 
-CCCTTTT-3
 
 
 
indicated 
 
gld 
 
and 5
 
 
 
-CC(C/T)TTTT-3
 
 
 
 indicated a heterozygote
(unpublished data).
 
Quantitative Analyses of Atherosclerosis, Hyperlipidemia, Spleno-
megaly, and Lymphadenopathy. 
 
After 12 wk on a Western or nor-
mal diet, food was removed for an 8-h fast. After the fast, the mice
were weighed and sacrificed. Blood was drawn by cardiac punc-
ture for determination of total plasma cholesterol and triglyceride
levels (Excell Labs). Heart, spleen, and submandibular lymph
nodes were excised and weighed. The vasculature was perfused
intracardially with 0.9% sodium chloride, and the aorta was iso-
lated from the aortic arch to the iliac bifurcation. The adventitia
was thoroughly stripped, and the aorta opened longitudinally,
pinned to a white silicone gel, and fixed in 10% neutral buffered
formalin for 24 h. After fixation, aortae were rinsed with PBS,
stained with Oil red O solution, and destained in 60% isopropyl
alcohol. Aortae were photographed using an Olympus digital
camera, and lesion size was measured using a National Institutes of
Health image program on a Macintosh computer. Because there
was no significant difference in lesion area between males and fe-
males (unpublished data), datasets for both sexes were combined.
 
Cell Isolation and Flow Cytometry. 
 
Lymph nodes were har-
vested, minced, and put through a 70-
 
 
 
m cell strainer. Cells
were washed in 2% FBS/PBS and stained for 15 min at 4
 
 
 
C.
Flow cytometry analysis was performed using fluorescence-
labeled monoclonal antibodies against the following: CD3-CyC,
CD4-FITC, CD8-PE (BD Biosciences), or TdT-mediated dUTP
nick-end labeling (TUNEL; Roche Diagnostics Corp.).
 
Immunohistochemistry. 
 
Aortae were fixed using 10% neutral
buffered formalin and paraffin embedded. 6-
 
 
 
m sections of aorta
were cut from the aortic arch to the thoracic aorta. Slides were
deparaffinized, treated with 3% hydrogen peroxide for 30 min,
and blocked in 10% goat serum using an avidin/biotin block.
Samples were incubated overnight at 4
 
 
 
C in rat anti–mouse F4/
80 (dilution 1:40; Serotec, Inc.), rat anti–mouse CD3 (dilution
1:1,000; BD Biosciences), or mouse IgG as a negative control in
5% goat serum/PBS. After washing, samples were incubated for
30 min in goat anti–rat IgG diluted 1:500 (Caltag). Visualization
of immune complexes with streptavidin–horseradish peroxidase
and aminoethylcarbazole was followed by a hematoxylin coun-
terstain. Macrophage and T cell quantification were determined
by scoring samples from at least eight mice per group, choosing
every sixth slide from the aortic arch through the thoracic aorta.
Analysis was performed by two investigators who were blinded
to the sample identity. Lymph nodes were fixed and sectioned
according to the aforementioned protocol. TUNEL staining was
performed according to the manufacturer’s directions (Roche
Diagnostics Corp.). Quantification of all TUNEL staining was
performed by examining six randomly selected fields in each
lymph node section by two investigators who were blinded to
sample identity. To generate the overlapping merged figures, se-
quential sections were used for fluorescent staining of macro-
phages and follicular dendritic cells with anti–mouse F4/80
(Caltag) and anti–mouse CD21 (BD Biosciences). Macrophage 
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ingestion of TUNEL-positive apoptotic debris was quantified as
described previously (3).
 
Autoantibodies. 
 
Serum levels of antinuclear antibodies (ANAs)
were measured by immunofluorescence using Hep-2–coated
slides (The Binding Site Inc.). Slides were incubated for 20 min
with serial dilutions (1:40 to 1:2,560) of mouse serum in PBS,
washed in PBS, and incubated with FITC-labeled goat anti–
mouse IgG (whole molecule; Sigma-Aldrich). Slides were coun-
terstained with Evan’s blue and viewed using fluorescent micros-
copy. The titer value is defined as the inverse value of the last
positive dilution. Anticardiolipin antibodies were measured using
a commercially available ELISA assay that detected IgG (Alpha Di-
agnostic). Values are reported as the mean absorbance. Serum IgG
levels were measured using a commercially available ELISA assay
(Bethyl Laboratories).
 
Kidney Analysis. 
 
Urine samples were obtained using met-
abolic cages from 19-wk-old wild-type, apoE
 
 
 
/
 
 
 
, 
 
gld
 
, and
 
gld.apoE
 
   
 
 mice maintained on normal diet. Samples were di-
luted 1:10 and measured using a protein assay (Bio-Rad Labora-
tories) at an absorbance of 595 nm. Calculations are shown as
milligrams of protein per 24 h. Formalin-fixed kidney sections
were stained with hematoxylin and eosin. Stained sections were
coded, digitally photographed, and analyzed by an investigator
who was blinded to section identity using a stereo microscope
(Nikon) fitted with a digital camera (Diagnostic Instruments).
Glomerular cross-sectional areas of at least 25 glomeruli from five
randomly photographed low-powered fields were measured in
each animal using computer-assisted pixel counting (Photopaint
10; Corel Corporation). Mean glomerular tuft area (A
 
G
 
) for each
animal was calculated from all available glomerular profiles, and
tuft volume (V
 
G
 
) was calculated as well (28). V
 
G
 
 
 
 
 
 (B
 
/
 
k)(A
 
G
 
)
 
1.5
 
where B is the shape coefficient for an idealized glomerulus (B 
 
 
 
1.38) and k is a size distribution coefficient (k 
 
 
 
 1.10).
 
Serum Microparticles. 
 
Platelet-free plasma was isolated and an-
alyzed as described previously (29). In brief, whole blood was
mixed with 0.138 M sodium citrate and centrifuged. After re-
trieval of the plasma, microparticle concentration was determined
by capture onto insolubilized annexin V and reported as the na-
nomolar concentration of phosphatidylserine equivalents.
 
Intravenous Infusion. 
 
6-mo-old wild-type or 
 
gld
 
 mice were
anesthetized with an intraperitoneal injection of sodium pento-
barbital and maintained with supplementary doses as needed. A
catheter was inserted into the tail vein for the intravenous infu-
sion of freshly prepared lysophosphatidylcholine (LPC) at rates of
1.5 or 3 pmol/min. Body temperature was maintained by a heat-
ing pad. Mice were killed 120 min after the start of infusion.
Lymph nodes were harvested, fixed in 10% formalin, and pro-
cessed for TUNEL staining as described previously.
 
Statistical Analysis. 
 
Results are shown as the mean 
 
 
 
 SEM.
Differences between groups were determined by analysis of vari-
ance and Student’s 
 
t
 
 test using the InStat program and were con-
sidered statistically significant for P 
 
 
 
 0.05.
 
Results
 
Lack of FasL in apoE
 
   
 
 Mice Leads to Greater Atherosclerotic
Lesion Area. 
 
The aortae of 
 
gld.apoE
 
   
 
 and 
 
apoE
 
   
 
 mice
maintained on a 12-wk Western diet demonstrated grossly
visible atherosclerotic lesions after Oil red O staining. Le-
sion area in the 
 
apoE
 
   
 
 mice in this work was in agree-
ment with previously described values (30). Considerably
greater lesion area was present in the 
 
gld.apoE
 
   
 
 mice
compared with 
 
apoE
 
   
 
 throughout the length of the aorta
(Fig. 1 a). Image analysis revealed a threefold increase in
plaque area in the aorta of the 
 
gld.apoE
 
   
 
 mice compared
with 
 
apoE
 
   
 
 (27.9 
 
 
 
 2.84 mm
 
2 and 9.10   0.9 mm2, re-
spectively; P   0.001) (Fig. 1 c). Lesion area analyses were
also performed on age-matched mice that were maintained
on normal diet (Fig. 1 b). Again, gld.apoE    mice had sig-
nificantly larger amounts of lesion area when compared
with apoE   : 6.7   0.5 mm2 and 2.1   0.3 mm2, respec-
tively (P   0.001) (Fig. 1 c). In contrast, gld and wild-type
mice had virtually no detectable lesions on either Western
or normal diet.
Inflammation and Apoptotic Bodies in Vascular Lesions.
Histological analysis of aortae of gld and wild-type mice
with the macrophage marker F4/80 or the T cell marker
CD3 revealed no evidence of macrophage or T cell infil-
tration (unpublished data), which was consistent with the
lack of visible lesions within these vessels. In contrast, the
aortae of gld.apoE    and apoE    displayed evidence of
macrophage and T cell extravasation within lesions (Fig. 2,
a, b, d, and e). Quantitative analyses revealed approxi-
mately threefold more macrophage staining in the vessel
cross-sections from the gld.apoE    than the apoE    mice
(Fig. 2 c). Examination of T cells revealed a similar result,
showing an increase in T cells within the lesions in the
gld.apoE    mice relative to the apoE    mice (Fig. 2 f).
TUNEL immunofluorescence staining of vessel segments
revealed apoptotic cells within the atherosclerotic lesions of
the apoE    mice that can be distinguished from the back-
ground autofluorescence of the elastic lamina (Fig. 2 g).
Figure 1. Atherosclerotic lesions in the
aortae of gld.apoE    and apoE    mice are
visualized by Oil red O staining. The increase
in atherosclerotic lesion area of the
gld.apoE   , compared with the apoE   , is
macroscopically visible on (a) Western diet, as
well as (b) normal diet. The gld and wild-type
mice showed no visible lesions (not depicted).
(c) Quantification of Oil red O staining area
revealed a statistically significant increase in
lesion size on Western diet of the gld.apoE   
(n   26) compared with the apoE    (n  
27), and normal diet gld.apoE    (n   11)
compared with the apoE    (n   8) (*, P  
0.001 vs. apoE   ).Autoimmunity, Atherosclerosis, and Impaired Apoptotic Cell Clearance 1124
The frequency of TUNEL-positive cells in these lesions
was low, consistent with a previous paper (31). In contrast,
markedly higher levels of TUNEL-positive fragments were
apparent in the vessel wall lesions of the gld.apoE    mice
(Fig. 2 h). Apoptotic debris typically localized near the lu-
menal surface of the vessel wall, although some positive
staining was present within the lesion.
FasL Deficiency Reduces Cholesterol Levels in apoE-deficient
Mice.  Total plasma cholesterol was determined for all
groups of mice on both Western diet and normal diet (Fig.
3 a). Although the gld.apoE    mice became hypercholester-
olemic on Western diet, the extent of hypercholesterolemia
was less than that of apoE    mice. There was also a trend
toward lower cholesterol levels in the gld.apoE    relative to
the apoE    in the mice fed normal diet, but this was not
statistically significant. With either diet, the gld mice had
lipid plasma levels similar to the wild-type controls. Com-
pared with control mice, apoE    mice showed a mild in-
crease in plasma triglyceride levels when fed Western diet
and normal diet, consistent with previous papers (30) as did
the gld.apoE    (unpublished data). Fast performance liquid
chromatography on each of the four experimental groups
was performed on pooled serum samples. The gld.apoE   
and apoE    had profiles containing higher very low density
lipoprotein (VLDL) and low density lipoprotein (LDL) lev-
els, and low high density lipoprotein levels compared with
the gld and the wild-type mice (Fig. 3 b and not depicted).
VLDL levels were lower in gld.apoE   mice compared with
apoE    mice. There was no significant difference in lipid
profile between the gld and the wild-type mouse on normal
diet and Western diet (unpublished data).
Lack of apoE Exacerbates gld Phenotype.  At the time of
killing, body weight and heart weight showed little or no
difference in the four strains of mice (unpublished data). In
contrast, spleen and lymph nodes from gld and gld.apoE   
mice showed remarkable increases in weight and size. Al-
though enlargement of these two organs is a characteristic
of the gld phenotype, the spleen and lymph nodes of
gld.apoE    mice were significantly larger when compared
with their gld counterparts (Fig. 4, a and b). Spleen weight
of gld.apoE    mice increased to almost double that found
for gld in animals fed a Western diet (0.75   0.07 g vs.
0.34   0.05 g; P   0.001), and approximately fivefold
that found in wild-type or apoE    mice (Fig. 4 c). This
trend in spleen size was also observed for these strains
when maintained on normal diet: 0.33   0.05 g for
gld.apoE    and 0.25   0.03 g for gld (P   0.05). Quanti-
fication of the submandibular lymph nodes also revealed a
Figure 2. Vessel wall inflammation is increased in
gld.apoE    mice compared with apoE    mice. Repre-
sentative sections of atherosclerotic lesions from the
aortic arch of the gld.apoE    and apoE    mice, main-
tained on a Western diet for 12 wk. Specimens were
stained with F4/80 for macrophages, or (d and e) CD3
for T cells, represented by the brown staining (arrows).
The increase of macrophages and T cells is quantified
in c and f, respectively. Macrophages and T cell content
were significantly higher in the lesions of gld.apoE   
mice (n   11) compared with apoE    (n   10) (*, P  
0.001  vs.  apoE   ). (g) Representative photomicro-
graph of TUNEL staining in lesions of apoE    mice.
(h) Representative photomicrograph of TUNEL staining
in lesions of gld-apoE    mice showing a greater amount
of TUNEL-positive fragments than in the apoE   
lesions. The ( )TUNEL condition indicates sections
processed without the terminal deoxynucleotidyl trans-
ferase enzyme to assess background autofluorescence of
the elastic lamina.Aprahamian et al. 1125
statistically significant increase in weight comparing the
gld.apoE    with the gld: 0.07   0.02 g for wild type ver-
sus 0.1   0.002 g for apoE   , and 0.40   0.07 g for gld
versus 1.05   0.08 g for gld.apoE    (P   0.001) when
maintained on a high-cholesterol Western diet (Fig. 4 d).
Likewise, a similar pattern was observed for mice main-
tained on normal diet.
CD4  T cells are important for autoantibody production
and the pathogenesis of autoimmunity, and the lympho-
proliferation seen in Fas or FasL-deficient mice and humans
is due predominantly to the expansion of an unusual T cell
population that is CD3 , but lacks both CD4 and CD8
(double negative T cells; reference 32). We performed a
phenotypic analysis of lymph node T cells from gld and
gld.apoE    mice to determine whether the enhanced lym-
phoproliferation and autoimmunity seen in the gld.apoE   
mice could be accounted for by obvious alterations in the
ratio of the different T cell subsets (Table I). No significant
differences in percentages of CD4 , CD8 , or double neg-
ative CD3 CD4 CD8  T cells were seen. The total num-
ber of all T cell subsets was increased in the gld.apoE   
mice (unpublished data), reflecting their larger lymph node
Figure 3. Lipid profiles of
apoE    and gld.apoE    mice
maintained on normal diet and
Western diet. (a) Total choles-
terol levels were determined in
gld.apoE    ( n    32), apoE   
(n   31), gld (n   26), and wild
type (n   31) on Western diet
and in gld.apoE    ( n    11),
apoE    (n   8), gld (n   5), and
wild type (n   5) on normal diet
(*, P   0.001 vs. gld, wild type;
†, P   0.001 vs. apoE   ). (b) Fast
performance liquid chromatog-
raphy profiles of sera from
gld.apoE    and apoE    mice
maintained on normal and West-
ern diet. VLDL, LDL, and high
density lipoprotein fraction loca-
tions are indicated.
Figure 4. Lymphadenopathy
and splenomegaly in gld and
gld.apoE    mice. (a) Represen-
tative spleens excised from paired
littermates of wild-type, gld, and
gld.apoE    mice. (b) Represen-
tative submandibular lymph nodes
(arrows) dissected from paired
littermates of wild-type, gld, and
gld.apoE    mice. Inset shows
higher magnification image of
lymph node from wild-type
mouse. Diagram illustrates dis-
sected area. (c) Spleen weights in
the different strains of mice fed
normal diet: gld.apoE    ( n   
11), apoE    (n   8), gld (n   5),
and wild type (n   5); or Western
diet:  gld.apoE    ( n    26),
apoE    (n   31), gld (n   26),
and wild type (n   31) (*, P  
0.001 vs. gld; †, P   0.05 vs. gld;
‡, P   0.001 vs. apoE   , wild
type). (d) Lymph node weights
in the different strains of mice
fed normal diet: gld.apoE    (n  
11), apoE    (n   8), gld (n   5),
and wild type (n   5); or Western
diet:  gld.apoE    ( n    26),
apoE    (n   31), gld (n   26),
and wild type (n   31) (*, P  
0.001 vs. gld;  †, P   0.001 vs.
apoE   , wild type).Autoimmunity, Atherosclerosis, and Impaired Apoptotic Cell Clearance 1126
size, which was most likely due to an overall enhancement
of the autoimmune process in these mice.
ANAs, the prototypic autoantibodies in SLE, were as-
sessed in the different lines of mice maintained on normal
diet or Western diets. As expected, wild-type and apoE   
mice showed no evidence of ANAs, whereas gld mice ex-
hibited high titers on normal diet and Western diet (Table
II). ANA titers in gld.apoE    were significantly elevated
compared with the gld mice on normal diet, and titers
were further elevated by Western diet. Serum levels of an-
ticardiolipin antibody (aCL) were modestly enhanced in
apoE    mice compared with wild-type, which was con-
sistent with a previous paper (33), and these levels were
further elevated by Western diet (Table II). The levels of
aCL were higher in gld mice than in apoE    mice and the
Western diet led to a further elevation of aCL in gld mice.
The gld.apoE    mice displayed the highest levels of aCL,
which were approximately fourfold higher than that seen
in  gld mice on either normal or Western diets. The
gld.apoE    mice also displayed elevated levels of IgG on
both normal and Western diet, indicative of a polyclonal B
cell activation (Table II).
Because autoimmune disease is frequently associated
with renal dysfunction, a histological analysis was per-
formed on the kidneys from the four strains of mice. Kid-
neys from gld.apoE    mice had larger, more cellular
glomeruli compared with all other strains (Fig. 5 a). Quan-
tification revealed that, whereas the wild-type, apoE   ,
and gld mice had glomerular tuft volumes of 1.6   106
 m3, 1.3   106  m3, and 2.1   106  m3, respectively, the
gld.apoE    volumes were significantly increased to 5.0  
106  m3 (Fig. 5 b). Correspondingly, proteinuria was ob-
served in the gld.apoE    mice (Fig. 5 c), a further indica-
tion of renal impairment.
Table I. Percent T Cell Composition of Lymph Nodes
CD4  CD8  CD3 CD4 CD8 
gld 13.0   4.8 5.9   2.1 43.3   9.7
gld.apoE    16.4   4.1 7.7   3.6 33.5   11.2
Figure 5. Evidence of renal dysfunction
in the gld.apoE    mouse. (a) Representative
hematoxylin and eosin stained sections of
renal tissue showing typical glomeruli in
gld.apoE    mice compared with wild-type,
apoE   , and gld mice when maintained on
Western diet. (top) Magnification, 100.
(bottom) Magnification, 400. (b) Quantifi-
cation of glomerular tuft volume revealed a
statistically significant increase in glomerular
size in the gld.apoE    mice compared with
the control groups (*, P   0.001). (c) The
output of urinary protein by gld.apoE   
mice maintained on normal diet was signifi-
cantly increased compared with wild type,
apoE   , and gld (*, P   0.001).Aprahamian et al. 1127
Increased Apoptotic Material and Impaired Clearance in gld.
apoE    Mice.  Apoptotic material was analyzed in the
sera and lymph nodes of the different groups of mice. Ap-
optotic fragments within the lymph nodes were visual-
ized using TUNEL immunofluorescent staining. Very few
TUNEL-positive fragments were observed in the wild-
type and apoE    mice (Fig. 6 a and not depicted). The gld
mice showed an increase in the frequency of TUNEL-pos-
itive fragments compared with wild-type or apoE    (Fig.
6 b). However, the frequency of TUNEL-positive frag-
ments was 40% higher in the gld.apoE    mice than in the
gld (P   0.01), and higher levels of apoptotic nuclei were
seen when gld.apoE    mice were fed a Western diet (P  
0.05) (Fig. 6, c and d). These histological results were cor-
roborated by FACS® analysis of TUNEL-positive frag-
ments (Fig. 6 e).
A microparticle analysis was performed on platelet-free
plasma using annexin V capture to assess the levels of apop-
totic microparticles in the circulation (29). Although the
differences between experimental groups was not as strik-
Table II. Circulating Autoantibody Levels
ANA (titer)a aCL Serum IgG
Normal diet Western diet Normal diet Western diet Normal diet Western diet
A A mg/ml mg/ml
WT ND ND 0.056   0.03 0.067   0.04 0.79   0.60  0.61   0.06 
apoE    ND ND 0.084   0.02 0.154   0.06 0.02   0.57 0.77   0.17
gld 104   24 120   25 0.164   0.02 0.193   0.03 0.19   0.59 1.79   0.51
gld.apoE    400   80b 823   118b,c 0.658   0.16b 0.859   0.31b   5.53    2.85d   4.25    0.72d 
aInverse titer of last positive dilution.
bP   0.001 versus WT, apoE   , gld.
cP   0.05 versus gld.apoE    on normal diet.
dP   0.01 versus WT, apoE   , gld.
A, absorbance; aCL, anticardiolipin; ANA, antinuclear antibody.
Figure 6. Elevated apoptotic fragments in lymph node and circulation of gld.apoE    mice. (a–c) Lymph node sections from animals fed Western diet
were stained with TUNEL (FITC) and (d) quantified showing number of TUNEL-positive cells in the different strains of mice maintained on normal or
Western diet (*, P   0.05 vs. gld.apoE    on normal diet). gld.apoE    also showed a significant increase in TUNEL-positive cells compared with gld
mice on normal or Western diet, respectively. Insets in a–c show higher magnification views. (e) FACS® analysis of TUNEL-positive cells in freshly iso-
lated lymph node from Western diet–fed mice corroborates the histological findings (*, P   0.05 vs. gld; P   0.01 vs. WT, apoE   ; †, P   0.05 vs. WT,
apoE   ). (f) Platelet-free plasma isolated from different strains of mice on Western diet and assayed for apoptotic fragments by annexin V capture (*, P   0.05
vs. gld; P   0.01 vs. WT, apoE   ).Autoimmunity, Atherosclerosis, and Impaired Apoptotic Cell Clearance 1128
ing as that found with TUNEL analyses of lymph node
sections, the gld.apoE    mice showed significant increase
in total microparticle concentration, relative to wild-type
and apoE    mice (Fig. 6 f). The microparticle population
in gld.apoE    mice was  30% endothelial origin based on
an anti-CD31 colocalization procedure (reference 29 and
unpublished data).
Further histological analyses of lymph node sections from
gld.apoE    mice were performed to assess the uptake of ap-
optotic nuclear material by macrophages. Lymph node sec-
tions from gld and gld.apoE    mice displayed reduced
frequencies of macrophages with evidence of ingested
TUNEL-positive material compared with wild-type or
apoE    mice (Fig. 7, a and b). However, the decrease in
frequency of macrophages with engulfed apoptotic nuclei
was most evident in gld.apoE    mice (P   0.05 relative to
gld) (Fig. 7 c). Of note, the uptake of apoptotic nuclei by
macrophages in gld.apoE    mice was significantly reduced
when animals were fed Western diet compared with normal
diet (P   0.05). Therefore, lymph nodes from gld.apoE   
mice displayed greater accumulation of apoptotic debris,
whereas macrophages in these mice displayed a greater defi-
cit in their ability to engulf this material, and both of these
effects were more pronounced by a high cholesterol diet.
LPC Infusion Impairs Apoptotic Cell Clearance.  LPC is
the predominant phospholipid component of oxLDL that
is believed to mediate many of the proatherogenic activities
associated with hyperlipidemia (34). To test whether LPC
could interfere with the clearance of apoptotic bodies,
wild-type and gld mice were infused with LPC, and apop-
totic material accumulation in lymph nodes was assessed
(Fig. 8). For this experiment, two doses of LPC were cho-
sen that are known to have vasoactive properties in vivo
(35). LPC infusion led to a small, dose-dependent increase
in the frequency of TUNEL-positive fragments in lymph
nodes of wild-type mice. In contrast, infusion of LPC in gld
mice led to markedly greater accumulation of apoptotic de-
bris in lymph nodes. The level of apoptotic debris in lymph
node sections from gld mice infused with LPC was similar
to that seen in gld.apoE    mice fed Western diet (Fig. 6).
Discussion
Although it is widely accepted that inflammation plays a
role in atherosclerosis, the etiology of accelerated athero-
sclerosis associated with autoimmune disease is not well un-
derstood. In this work, a mouse model was created by cross-
ing a strain that is susceptible to atherosclerotic lesion
formation (apoE   ) with a strain that develops lymphopro-
liferation and autoimmunity (gld). The gld.apoE    mice dis-
played threefold more atherosclerotic lesion area in the aorta
than their apoE    counterparts on a Western diet. Surpris-
ingly, the gld.apoE    mice exhibited exacerbated lympho-
proliferation and autoimmunity relative to the gld pheno-
type, an effect that was further enhanced by Western diet.
These data demonstrate synergistic interactions between the
pathogenesis of atherosclerotic and autoimmune/lympho-
proliferative diseases in the gld.apoE    mouse.
Figure 7. Evidence of im-
paired macrophage function in
gld.apoE    mice. (a) Lymph
node sections of wild-type mice
stained with TUNEL (FITC)
and F480 (PE) show colocaliza-
tion of TUNEL-positive cells
and macrophages (arrows, yellow
merge). (b) Lymph node sections
of gld.apoE    mice stained with
TUNEL (FITC) and F480 (PE)
show an abnormal morphology
of macrophages and diminished
colocalization. (c) Quantified
results revealing a statistically
significant decrease of macro-
phage ingestion of TUNEL-posi-
tive fragments in the gld and
gld.apoE    mice, with gld.apoE   
mice decreasing further than gld
on both normal diet and Western
diet (*, P   0.05 vs. gld).
Figure 8. LPC promotes apoptotic body accumulation. LPC solutions
or saline were infused for 120 min via tail vein in wild-type or gld mice.
Lymph node sections were stained for TUNEL-positive cells. Quantified
results reveal a significant increase in TUNEL-positive cells in gld mice
after receiving LPC infusion (*, P   0.001).Aprahamian et al. 1129
The role of Fas-mediated apoptosis in the genesis of vas-
cular lesions is incompletely understood and controversial
(36). Deficiencies in Fas-mediated apoptosis will produce
vasculitis in some strains of mice (37) and promote intimal
hyperplasia in a flow-restricted model of vascular injury
(38). These data suggest that the Fas/FasL system is athero-
protective through its ability to inhibit vascular inflamma-
tion. However, acute overexpression of FasL or down-
stream effector molecules in wild-type animals was found
to activate a proinflammatory program and promote ath-
erosclerosis in some studies (39, 40), but not others (41,
42). The results of the current analysis show that, in toto,
the Fas/FasL system has an atheroprotective function and
that it serves to minimize vascular inflammation. In the
context of the apoE    background, a deficiency in Fas-
mediated apoptosis led to larger and more complex lesions,
containing increased amounts of inflammatory cells and ap-
optotic debris. These features, in combination with the au-
toimmune phenotype, make the gld.apoE    mouse strain a
relevant model system to study the pathophysiology of ac-
celerated atherosclerosis that occurs in patients with au-
toimmune disease (13–15).
The gld.apoE    mice displayed increases in lymphade-
nopathy, splenomegaly, and autoimmune antibodies against
cardiolipin and nuclear antigens compared with gld mice.
The  gld.apoE    mice also exhibited immune-mediated
glomerular injury. In this mouse model, abnormal glomer-
uli and increased urinary protein excretion rates were ob-
served. This is of particular interest because the strain of gld
mouse (B6) that was used in this work does not normally
exhibit appreciable renal dysfunction (43).
The interrelationship between vascular and autoimmune
diseases in this mouse model may be mediated by perturba-
tions in the mechanisms that clear apoptotic bodies. Recent
studies in patients with SLE and lupus-prone animal mod-
els suggest that autoimmunity can result from defects in the
ability to scavenge apoptotic bodies (3, 8). A key finding of
our analysis is the observation that gld.apoE    mice con-
tain significantly more TUNEL-positive nuclear fragments
in their lymph nodes and higher levels of circulating apop-
totic microparticles than the gld mice, consistent with the
aggravated autoimmune phenotype in these animals. De-
spite these increases in apoptotic material, macrophages in
gld.apoE    mice contained less apoptotic debris. The accu-
mulation of apoptotic cells is of significance because delays
in clearance will allow cells to enter late stages of apoptosis
and secondary necrosis, and thereby promote inflammation
(44). In addition, autoantigens become available for uptake
by dendritic cells (2, 8). This process can facilitate the
breakdown of peripheral tolerance through the effective
presentation of autoantigens to the immune system.
The impaired clearance of apoptotic bodies may also
have consequences for atherosclerotic disease. Patients with
acute coronary syndromes have elevated levels of circulat-
ing apoptotic microparticles (29). These particles are highly
thrombogenic and can account for the majority of the tis-
sue factor activity in the lipid core of vascular plaques (45).
In this regard, apoptotic fragments were found to be more
abundant in the sera and atherosclerotic plaques of the
gld.apoE    mice than the apoE    mice, and their accumu-
lation in the vessel wall could contribute to lesion progres-
sion. In addition, aCL was markedly elevated in the
gld.apoE    mice compared with gld or apoE    mice. aCL
is a marker of autoimmune diseases and a risk factor for
atherosclerosis and vascular complications (46, 47). An-
tiphospholipid antibodies may promote vascular inflamma-
tion by binding to apoptotic cells, thereby enabling their
recognition by macrophage Fc receptors (48). Although
macrophage phagocytosis of apoptotic bodies through
scavenger receptors is normally antiinflammatory, uptake
through Fc receptors can promote a proinflammatory state
that is associated with cytokine secretion (48). Finally, im-
mune complexes containing cardiolipin and other autoan-
tigens can directly trigger endothelial cell expression of
inflammatory cytokines and surface adhesion molecules,
leading to endothelial dysfunction and their conversion to a
prothrombotic phenotype (49).
It is interesting to speculate on how the process of
atherogenesis can promote the accumulation of apoptotic
bodies. OxLDL is a proatherogenic component of LDL
cholesterol. OxLDL and antibodies against oxLDL can in-
terfere with the recognition of the phosphatidylcholine
moieties on apoptotic bodies by macrophage scavenger re-
ceptors and inhibit their phagocytosis (50, 51). Thus, the
accumulation of apoptotic bodies in gld.apoE    mice
could result from oxLDL-mediated interference of macro-
phage function. Consistent with this hypothesis is the ob-
servation that gld.apoE    mice maintained on Western
versus normal diet displayed higher levels of apoptotic bod-
ies in lymph nodes and a lower frequency of macrophages
with ingested apoptotic debris. Furthermore, Western diet
also increased circulating autoantibody levels as well as
lymphadenopathy and splenomegaly. In this regard, we
found that the continuous infusion of LPC, a major com-
ponent of oxLDL, impairs apoptotic cell clearance. Al-
though these effects could be seen in wild-type mice, the
effects of LPC on apoptotic cell clearance were much more
robust in gld mice. Recent data have suggested that LPC is
a component of the phagocyte recruitment signals that are
secreted by cells undergoing apoptosis (52). Therefore,
high levels of LPC in hypercholesterolemic gld.apoE   
mice might interfere with signal gradients that are required
for the normal recruitment of phagocytes to dying cells.
In summary, the gld.apoE    model reflects the acceler-
ated atherosclerosis that occurs in patients with autoim-
mune disorders. These data suggest that the immune dys-
regulation associated with SLE and similar disorders plays a
key role in promoting atherogenesis. Our findings also in-
dicate a positive feedback interaction between atherogene-
sis and autoimmune disease. In this regard, hyperlipidemic
conditions may contribute to the severity of autoimmune
disease by promoting the accumulation of apoptotic debris.
Although it is difficult to ascertain the relationship between
serum lipid levels and disease severity in patient populationsAutoimmunity, Atherosclerosis, and Impaired Apoptotic Cell Clearance 1130
due to the prevalence of corticosteroid therapy, an analysis
of untreated pediatric SLE patients concluded that hyper-
lipidemia was associated with the active disease (53). Fur-
thermore, it has recently been reported that a cholesterol-
lowering diet improves quality of life in patients with SLE
(54). Therefore, further application of the gld.apoE   
model could be valuable in delineating the interplay be-
tween autoimmunity and vascular disease progression.
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